How It's Inherited
About the Sickle Cell Advocates of the Year Awards
The Sickle Cell Advocates of the Year (SCAY) is an annual award presented by Sickle Cell 101 to recognize devoted sickle cell advocates who have made invaluable strides towards the progression of sickle cell through their contributions and achievements.
The profile of a Sickle Cell Advocate of the Year is that of an individual that radiates a passion for sickle cell advocacy, while engaging the community and inspiring others to make a difference. They are educators, spokespeople, and supporters; they are positive representatives in the sickle cell community.
This award promotes patient engagement by allowing individuals within the sickle cell community to nominate sickle cell advocates that exemplify all of the qualities listed above. The 2017 SCAY Awards will be our 4th year in honoring these individuals. Last year we received over 140 nominations for 23 candidates.
Honoring a sickle cell advocate within the U.S.
Honoring a sickle cell advocate outside of the U.S.
Honoring a healthcare professional who advocates for sickle cell
The judging panel will consist of five or seven members of the sickle cell community, which will include a previous Sickle Cell Advocate of the Year Award recipients.
The SCAY Awards are open to individuals with associations to sickle cell. This includes individuals living with sickle cell, their family members, caregivers, and/or healthcare professionals; anybody doing great work for sickle cell. SCAY nominations are open to individuals within the U.S. and outside the U.S. Individuals must be able to prove their accomplishments through documentation.
• Selection Process
The judging panel reviews and evaluates all nominations before naming the Sickle Cell Advocates of the Year. Winners will be announced on Thursday, June 1, 2017.
• The final judgment will be based on the following two criteria:
Achievement & Community Impact
Candidate actively engages, and/or provides services to the sickle cell community. Candidate is a positive figure/role model, and their achievements have impacted people within the sickle cell community in a beneficial way.
Education & Awareness
Candidate educates and equips people with vital information and resources. Candidate raises awareness for the disorder by reaching various audiences.
Last Year's Sponsor
Our sponsor is Global Blood Therapeutics (also called GBT), a San Francisco-based, biopharmaceutical company dedicated to developing therapies to improve the lives of patients with blood-based disorders. The company’s lead drug candidate is called GBT440 and is currently being studied as an oral, once-daily therapy for SCD. GBT440 targets the underlying mechanism of red blood cell sickling. Currently, GBT440 is being investigated in an ongoing Phase 1/2 clinical trial in both healthy subjects and SCD patients. GBT plans to start additional trials including in pediatrics and other genotypes in 2016. For the latest information on GBT440 trials, you can visit ClinicalTrials.gov.
Social Media Education
Events & Outreach
WHAT'S SICKLE CELL?
Sickle Cell Disease
How It's Inherited
Sickle Cell Trait
Ask Dr. Q
Expert Opinion Pieces
Become a Member